Skip to main content
Fig. 1 | Alzheimer's Research & Therapy

Fig. 1

From: Plasma neurofilament light chain as prognostic marker of cognitive decline in neurodegenerative diseases, a clinical setting study

Fig. 1

Association of plasma NfL with cognitive function across diagnosis subgroups

Plasma NfL association with global cognition and specific cognitive domains by diagnosis subgroups, including AD, FTD, LBD, NND and SCD. Standardized estimates with the corresponding 95% CI were plotted for the association of baseline plasma NfL levels with baseline cognitive domain scores for each diagnosis group. Linear regressions were adjusted on age, sex and education level.

Back to article page

Alzheimer's Research & Therapy

ISSN: 1758-9193